The Dermoscopic Patterns in Patients with Acanthosis Nigricans and its Potential Relation to Duration and Management of Diabetes Mellitus
Published: 2023-10-06
Page: 102-111
Issue: 2023 - Volume 6 [Issue 1]
Rasha Mohamed
Department of Dermatology, Faculty of Medicine (for Girls), Al-Azhar University, Egypt.
Hanan M. Darwish
Department of Dermatology and Venereology, Faculty of Medicine (for Girls), Al-Azhar University, Egypt.
Marwa Said *
Department of Dermatology and Venereology, Faculty of Medicine (for Girls), Al-Azhar University, Egypt.
*Author to whom correspondence should be addressed.
Abstract
Background: Acanthosis nigricans (AN) is associated with endocrine dysfunction, especially insulin resistance and hyperinsulinaemia, as seen in diabetes mellitus (DM). Clinical and dermoscopic findings of AN are associated with the control of DM.
Aim: This study aims to evaluate the dermoscopic patterns in patients with AN and its relation to the duration and control of diabetes mellitus.
Materials and Methods: This Comparative analytical cross-sectional study was conducted Prediabetic patients (20 patients) complaining of AN with age ranging from 30 to 52 years old (2 male and 18 female) and Patients of chronic diabetes mellitus of different durations (20 patients), complaining of AN with age ranging from 33 to 60 years old (5 male and 15 female); we investigated HbA1C level and random blood glucose, in addition to dermoscopic examination of AN were performed using the dermoscope (DL4).
Results: Significant positive correlation between dermoscopic findings of AN and BMI, random blood glucose and HbA1C of both groups. Significantly positive correlation between (hyperpigmented dots, hyperpigmented globule and papillary projection) of dermoscopic findings of AN and clinically hyperpigmented patch and Velvety-like appearance of both groups. Significant increase in papillary projection, hyperpigmented dots and hyperpigmented globule in Group II compared to Group I.
Conclusion: Significant positive correlation between dermoscopic findings of acanthosis nigricans and BMI, RBG and HbA1C of both groups. The Severity of clinical appearance of AN is related mainly to level of blood glucose and IR so it more marked in the diabetic group than the prediabetic group.
Keywords: Acanthosis nigricans, diabetic mellitus, dermoscopy
How to Cite
References
Kutlubay Z, Engin B, Bairamov O and Tüzün Y. Acanthosis nigricans: A fold (intertriginous) dermatosis”. Clin Dermatol. 2015;33:466–70.
Miller J. Acanthosis Nigricans. E Medicine Dermatology; 2009.
Innaurato S, Brierley GV, Grasso V, Massimi A, et al. “Severe insulin resistance in disguise: A familial case of reactive hypoglycemia associated with a novel heterozygous INSR mutation”. Pediatr Diabetes. 2018;19:670–674.
Brady MF, Rawla P. “Acanthosis Nigricans”. In: StatPearls. Treasure Island (FL): StatPearls. 2022;28613711.
Verma, Shyam, Vasani, Resham, Joshi, et al. A descriptive study of facial acanthosis nigricans and its association with body mass index, waist circumference and insulin resistance using HOMA2 IR. Indian Dermatology Online Journal. 2016;7:498–503.
Hartman R, Defelice T, Tzu J, Meehan S, et al. Acanthosis nigricans in the setting of niacin therapy”. Dermatol Online J. 2011;17:11.
Sokołowska-Wojdyło, Kłudkowska, Olszewska,Seredyńska, Biernat,Błażewicz, et al. The first case of drug-induced pseudoscleroderma and eczema craquelé related to nab-paclitaxel pancreatic adenocarcinoma treatment” Postepy Dermatol Alergol. 2018;35:106.
Lee SS, Jung NJ, Im M, Lee Y, et al. Acral-type malignant acanthosis nigricans associated with gastric adenocarcinoma”. Ann Dermatol. 2011;23:208–10.
Bhagyanathan Meera, Deepak Dhayanithy, Vijayan Ampaya Parambath, and R. Bijayraj. “Acanthosis nigricans. A screening test for insulin resistance – An important risk factor for diabetes mellitus type-2”. J Family Med Prim Care. 2017;6:43–46.
Wilson and Mara Lynn. Prediabetes. Nursing Clinics of North America. 2017;52:665–677.10.
Zheng Y, Ley SH and Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications”. Nat Rev Endocrinol. 2018;14:88-98.
Roden M, Shulman GI. The integrative biology of type 2 diabetes”. Nature.2019;576:51–60.
Dinulos JGH. Cutaneous manifestations of internal disease”. Clinical Dermatology. 2021;chap 26
Marghoob AA. Current status of dermoscopy in the diagnosis of dermatologic disease. J Am Acad Dermatol. 2013;2:252-53.69.
Uchida S, Oise N, Suzuki T and Kawada A. Dermoscopic features of hyper pigmented dots in crista cutis with inherited acanthosis nigricans”. J Cosmetics Dermatol Sci Appl.2012;2:252-53.
Sonthalia S, Gupta A, Jha AK and Sarkar R. Hyperpigmented disorders (disorders of pigmentation)”. Dermoscopy in General Dermatology. London: CRC Press. 2019;257-69.
Smid CJ, Madoff P, Alade A, Legare JM, et al. Acanthosis nigricans in achondroplasia. Am J Med Genet. 2018;176:2630-2636.
Mark F. Brady, Prashanth Rawla. acanthosis nigricans”. national center for biotechnology information. 2021;28613711.
Ranglani and Harshal. “Dermoscopic features of acanthosis nigricans”: A case series. International Journal of women dermatology. 2019;5:282.
Khaled K. Aldossari, Abdulrahman Aldiab, Jamaan M. Al-Zahrani, Sameer H. Al-Ghamdi, et al. “Prevalence of Prediabetes, Diabetes, and Its Associated Risk Factors among Males in Saudi Arabia”. A Population-Based Survey. 2018;2194604.
Byung-Gue Lee, Kyung Hee Park, Young-Gyun Seo, Hye-Mi Noh, et al. “Insulin Resistance and Obesity according to degree of acanthosis nigricans in obese korean children and adolescents” Korean J Fam Pract. 2020;332-337.
Yung-Gue Lee, Kyung Hee Park, Young-Gyun Seo, Hye-Mi Noh, et al., Insulin Resistance and Obesity according to Degree of Acanthosis Nigricans in Obese Korean Children and Adolescents, Department of Family Medicine”. Korean J Fam Pract. 2020;10: 332-337.
Antonio Videira-Silva, MSc, Carolina Albuquerque, MD, MSc, and Helena Fonseca, MD. “Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents” Ann Pediatr Endocrinol Metab. 2019;24: 99–103.